David Michael Williams, Executive Vice President and Chief Information & Digital Officer at Merck (NSE:PROR) & Co., Inc.

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

GMO's portfolio update highlights key stock adjustments and forecasts a promising 9.6% return for International Deep Value ...

These S&P 500 stocks with dependable dividends and Buy ratings look like incredible contrarian ideas for growth and income ...

Moderna (NASDAQ:MRNA) is scheduled to announce Q4 earnings results on Friday, February 14th, before market open. Analysts expect a loss of $2.73 on revenue of $941.14M (-66.5% Y/Y). According to BofA ...

Large-cap Health Care company Merck & has moved -10.5% so far today on ... of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or ...

Bearish flow noted in Merck (MRK) with 177,294 puts trading, or 7x expected. Most active are Feb-25 98 puts and Feb-25 100 puts, with total ...

U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Non-Cum. Perp. Pfd. Series K) 1.15% U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L) 0.86% U.S. Bancorp Dep. Pfd ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Buying stocks is quick and straightforward once you have a brokerage account. Learn how with this step-by-step guide. Many, or all, of the products featured on this page are from our advertising ...